The membrane-restricted NKG2D ligand MICB.A2 could sustain NKG2D protective immunity and prevent spontaneous tumorigenesis, whereas the native NKG2D ligand MICB facilitates tumor progression through soluble ligand-mediated impairment of NK cell peripheral maintenance [342]. Here, KLRK1 is linked to neoplasm.